This week's sponsor is Premier Research. | | New Insights in the Battle Against Alzheimer’s
Thanks to awareness efforts like World Alzheimer’s Day this Friday, there’s a relentless focus on finding breakthrough therapies for this ravaging disease. Our new white paper looks at how we’re combating this growing epidemic. Premier Research. It’s what we do. Best. |
Today's Rundown Featured Story | Tuesday, September 18, 2018 Novo Nordisk is laying off 400 employees in China and Denmark as part of a reorganization of its R&D department. The reshuffle comes as the company seeks to build a pipeline of chronic disease drugs capable of mitigating the pressures faced by its core diabetes business. |
|
|
Top Stories Tuesday, September 18, 2018 Another scientist who previously worked for GlaxoSmithKline has admitted conspiring to steal trade secrets from the company and pass them on to a Chinese rival. Tuesday, September 18, 2018 Servier has turned down the chance to license a multiple sclerosis drug from GeNeuro. The decision comes a year after the monoclonal antibody, GNbAC1, failed to beat placebo in a phase 2b trial. Monday, September 17, 2018 Clinical research sites have a tough, but critically important, job. It’s rigorous and precise work, but essential to the progress of medicine. Tuesday, September 18, 2018 Allergan and Sosei have voluntarily paused development of HTL0018318 after tests in nonhuman primates uncovered unexpected toxicology findings. Phase 1 and 2 clinical trials of the muscarinic M1 receptor agonist are on hold while the partners investigate the toxicology results. Tuesday, September 18, 2018 Roivant Sciences’ spinout machine keeps turning, with the launch of the lung-disease focused Respivant Sciences, a company built around an inhaled drug for treating chronic cough in patients with idiopathic pulmonary fibrosis. Tuesday, September 18, 2018 Virion Biotherapeutics announced Monday that Vanessa King and Isabel Najera have signed on as CEO and chief scientific officer, respectively. Tuesday, September 18, 2018 Viking Therapeutics’ lead lipid disorder asset met its primary and secondary endpoints in a midstage trial, dropping cholesterol and liver fat levels in patients with nonalcoholic fatty liver disease. Tuesday, September 18, 2018 BioTime has appointed Brian Culley to serve as its sole CEO, as part of a corporate restructuring executed by the board of directors. Culley takes over for co-CEOs Adi Mohanty and Michael West, effective immediately. Monday, September 17, 2018 Scientists at Genentech have perfected a naturally occurring molecule so it can penetrate E. coli and other Gram-negative bacteria. The discovery could lead to a whole new class of antibiotics. Monday, September 17, 2018 This year, we’re hoping to continue spotlighting the most innovative and promising private startups in the medtech industry, and we need your help. This week's sponsor is the Fierce Innovation Awards – Life Sciences Edition. | | |
Resources Sponsored by: Amazon Web Services Download our new eBook to learn how Healthcare and Life Sciences organizations are taking advantage of solutions from AWS and the AWS Partner Network to obtain value from critical data. Sponsored by: Veeva A top 20 pharma and growing biotech re-engineer regulatory processes. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Covance FSPx Covance FSPx boasts one of the world’s largest dedicated FSP groups in the contract research organization space with ~4200 staff in 60+ countries. Sponsored by: Sciformix Are automation, big data and artificial intelligence (AI) a key part of your company’s pharmacovigilance strategy? Read this whitepaper to know what they should be! Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. Sponsored by: Patheon, part of Thermo Fisher Scientific When developing a parenteral, pharmaceutical scientists are faced with a variety of choices – choices that can be conflicting or present differing advantages. Sponsored by: Baxter Baxter BioPharma Solutions’ whitepaper offers a method to address the challenges of tech transfer for lyophilized products from lab-scale to commercial-scale. Sponsored by: Blue Matter A whitepaper outlining the key commercial challenges facing rare disease products, and how biopharmaceutical companies can overcome them. Sponsored by: AWS and Tableau Inova is using the capabilities of Tableau on AWS to identify biomarkers for personalized treatment intended to improve health outcomes for children. Sponsored by: AWS and Reltio Reltio and IQVIA provide holistic data management solutions for traditional pharma, emerging biotech, and consumer health companies, on AWS. Presented by: AWS and Druva Life Sciences organizations are embracing cloud-based Master Data Management (MDM) to modernize the organization of critical data. Sponsored by: Health Strategies Group The window of market exclusivity continues to narrow dramatically in the global marketplace. Given this demanding environment, your global market access team faces increasing urgency to get the value proposition right at the time of launch. Sponsored by: PharmaCord When was the last time your patient support program perfectly aligned with the patient journey, solving all the critical gaps in positioning your brand for success? Follow the 3-D approach to your solution design, and you will achieve a better outcome for your patients. Sponsored by: Catalent Develop a basic understanding of principles and concepts of bioavailability of oral drugs. Drug Approval, Manufacturing Quality & Regulation 2018 | Online Drug Development Boot Camp® 2018 – Registration closes 30 October - Register Now! November 14-15, 2018 | Boston, MA | Registration closes on the 30 of October 2018 due to the need for participants to complete pre-Boot Camp preparations. Register now and start preparing for this intensive training in drug development. 2018 Latin America Healthcare Compliance Certification Program September 24-27, 2018 | Sao Paulo, Brazil FierceBiotech 3rd Drug Development Forum October 1–3, 2018 | Hilton Boston Logan Airport Hotel | Boston, MA Compliance Certification Program at Seton Hall Law October 8-11, 2018 | Newark, NJ BioImmersion: Biotech for the Non-Scientist October 16-18, 2018 | Chicago, IL Fierce Innovation Awards: Life Sciences Edition 2018 FierceBiotech Executive Summit: London October 30, 2018 | Royal Society of Medicine Understanding Commercialization Within Biopharma Nov 7-8, 2018 | Boston, MA Drug Development Immersion December 5-6, 2018 | San Diego, CA Understanding Drug Pricing and Reimbursement December 12, 2018 | Boston, MA |